Ranked GEO Datasets

Active GEO index contains 44678 ranked datasets; organism mixed: Homo sapiens (32691), Mus musculus (11987); assay type mixed: microarray (24292), bulk RNA-seq (19023), other assay type (1363). Rankings use the Patient tissue tumor-vs-normal intent with transparent suitability, metadata quality, and warning rules.

Gene snapshot Projects Saved searches CSV Markdown
9 shown of 159 matching datasets Scoring intent-aware-scoring-v19 Batch d7cf15dd0c99080c1120bd13973fb94ebabdf757613abc5dc551f884f6e917ac Intent Patient tissue tumor-vs-normal Organism Homo sapiens Assay bulk RNA-seq Intent defaults Active 5 active filters Page 4 of 4 · showing 151-159
Active intent defaults Tumor-normal onlyTissue or biopsy onlyHide biofluid/model systemsHuman onlyBulk RNA-seq only
Study designs tumor vs matched normal or tumor vs unmatched normal
Recommendation Recommended means a human bulk RNA-seq tissue or biopsy cohort with clear tumor-normal grouping and sufficient metadata for first-pass triage.
Search intent
Intent defaults Relax defaults

Showing one page of matching results. Use next/previous for browsing, or CSV/Markdown export for the full matching set.

151
GSE236932

Whole Transcriptome Sequencing Identifies a Competitive Endogenous RNA Network that Regulates the Immunity of Bladder Cancer [RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 63 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
152
GSE252600

Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis [RNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 18 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
153
GSE273036

Multi-Omics Analysis and Molecular Subtypes Provide Potential Therapeutic Implications in Fumarate Hydratase-deficient Renal Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 93 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
154
GSE285848

Gene expression profiling of clear cell renal cell carcinoma with sarcomatoid transformation

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
155
GSE299125

Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer Pathways

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 35 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
156
GSE29968

RNA Sequencing Analysis Generates Comprehensive Transcriptomic Landscape and Identifies PTK6 as a Novel Tumor Suppressor Gene in Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
157
GSE304579

Alternative End-Joining Activation by miR-21-5p Confers Radiation Resistance in Oral Squamous Cell Carcinoma [RNA-seq of SUGH-OSCC patient tumors]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 34 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
158
GSE32424

Identification of a Novel Angiogenesis and Tumor Suppressor Gene Rab25 in Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
159
GSE97239

High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.